Indian Journal of Pharmacology Home 

SHORT COMMUNICATION
[View FULLTEXT] [Download PDF]
Year : 2009  |  Volume : 41  |  Issue : 4  |  Page : 197--198

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes

Rajiv Mahajan 
 Department of Pharmacology, AIMSR, Bhatinda, India

Correspondence Address:
Rajiv Mahajan
Department of Pharmacology, AIMSR, Bhatinda
India




How to cite this article:
Mahajan R. Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes.Indian J Pharmacol 2009;41:197-198


How to cite this URL:
Mahajan R. Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes. Indian J Pharmacol [serial online] 2009 [cited 2020 Sep 23 ];41:197-198
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2009;volume=41;issue=4;spage=197;epage=198;aulast=Mahajan;type=0